Abstract
In this paper, we review our research in the use of UV and visible native fluorescence emission and excitation spectroscopy for the detection of cancer and precancer. We discuss some of the spectroscopic signatures indicative of the presence of cancer and precancer. We describe three generations of instruments being developed to extent optical biopsy technology into the clinical environment as both a screening tool and as a diagnostic aide suitable for gynecological, gastro-intestinal tract, oral cavity, brain and breast.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
